Volume 7 Issue 3 - International Biopharmaceutical Industry

Home
Current
Features
Editorial
Archives
Archived
Issues
Events
Sponsored
Report
Company
Profile
A-D

E-M

N-S

T-Z

Menu
Application
Notes
News
eBooks

Aldevron
Podcast
Generic selectors

Exact matches only

Search in title

Search in content

Post Type Selectors

Current Edition

Volume 7 Issue 3

Enhancing Therapeutic Antibody Development via Synthetic Phage Display Technology

Phage display technology has played a key role in the discovery and optimisation of antibodies for a wide range of clinical or research applications, with its greate...

30 September 2024 Volume 7 Issue 3 | Current Features

Continue Reading →

Volume 7 Issue 3

Understanding the Corporate Sustainability Reporting Directive in Europe and Its Implications for Medium-sized Companies

The issue of sustainability has garnered increasing attention across the globe, with particular emphasis on small and medium-sized enterprises (SME). These companies...

30 September 2024 Volume 7 Issue 3 | Current Features

Continue Reading →

Volume 7 Issue 3

Considerations on In Vitro Disease Models with Focus on Fibrosis

The evolution of disease modelling has seen a paradigm shift from the traditional use of animal models to more advanced in vitro human-based systems. This has been d...

30 September 2024 Volume 7 Issue 3 | Current Features

Continue Reading →

Volume 7 Issue 3

mRNA and AAV as Vectors for Novel Cell and Gene Therapies

Cell and gene therapies are treatments that currently revolutionise medicine as they have the potential to cure serious and incurable diseases. In cell therapy, livi...

30 September 2024 Volume 7 Issue 3 | Current Features

Continue Reading →

Volume 7 Issue 3

Bench to Bedside: A Roadmap for Developing Novel Gene Therapies

Gene therapy represents a groundbreaking approach in the field of medicine, aiming to treat or prevent diseases by modifying the genetic material within a patient's ...

30 September 2024 Volume 7 Issue 3 | Current Features

Continue Reading →

International Biopharmaceutical Industry

IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.

Current Edition

Upcoming Events

Advertisement

Enhancing Therapeutic Antibody Development via Synthetic Phage Display Technology

Understanding the Corporate Sustainability Reporting Directive in Europe and Its Implications for Medium-sized Companies

Considerations on In Vitro Disease Models with Focus on Fibrosis

mRNA and AAV as Vectors for Novel Cell and Gene Therapies

Bench to Bedside: A Roadmap for Developing Novel Gene Therapies

International Biopharmaceutical Industry